A new study links mitochondrial dysfunction to Crohn’s disease, shifting how scientists approach treatment and opening doors ...
ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s diseaseNew detailed data from the RELIEVE UCCD ...
French drug major Sanofi and the US unit of Israel’s Teva Pharmaceutical Industries have presented new, detailed results from the RELIEVE UCCD Phase IIb study of duvakitug, a human IgG1-λ2 monoclonal ...
For those who are actively trying to look younger, a doctor has revealed there’s one tell-tale sign on our bodies that can ...
I've had a stoma, I've had one toilet that's been completely accessible for me," says Emma Sellars. "It is a real downer to ...
Living with ulcerative colitis doesn’t mean giving up the flavors you love. You can enjoy delicious meals without painful ...
MyChesCo on MSN6h
Johnson & Johnson’s TREMFYA® Shows Promising Results in Ulcerative Colitis PatientsHOUSE, PA — Johnson & Johnson (NYSE: JNJ) has announced positive results from the Phase 3 ASTRO study evaluating TREMFYA® (guselkumab) subcutaneous (SC) induction therapy in adults with moderately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback